semaglutide vs placebo Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Efficacy and safety of subcutaneous semaglutide once-daily versus placebo in patients with nonalcoholic steatohepatitis Semaglutide Resolves NASH in Big Placebo-Controlled Trial

25.14

★★★★☆4.8 (126)

Semaglutide 2.4 mg weekly vs 1 mg and placebo in #obesity with T2 #diabetes Better weight loss, better reduction in waist circumference and slightly better HbA1c lowering (sugars) with fewer other sugar-lowering

22.35

★★★★★4.9 (98)

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

29.56

★★★★★5.0 (157)

PDF] Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

24.38

★★★★★4.7 (84)

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

29.15

★★★★★4.9 (203)

Variation in weight loss response for semaglutide andplacebo a,

26.85

★★★★★5.0 (176)

Semaglutide 7·2 mg was modestly superior to placebo and 2·4 mg (#wegovy) for #WeightLoss in adults with obesity, while retaining a favourable risk–benefit profile. We recently had the lead author on the

25.38

★★★★★4.8 (132)